Fatma Şemsa Çaycı

Fatma Şemsa Çaycı

Auto-generated profile, based on publicly available information

Fatma Şemsa Çaycı

Ankara Bilkent Şehir Hastanesi

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2012 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
FCF. Semsa Caycı
F. Semsa Caycı
NCNilgun Cakar
Nilgun Cakar
VHVeysel Sabri Hancer
Veysel Sabri Hancer
NUNermin Uncu
Nermin Uncu
BABanu Acar
Banu Acar
GGGokce Gur
Gokce Gur

1 October 2010 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
FAF. Şemsa Altugan
F. Şemsa Altugan
MEMesiha Ekim
Mesiha Ekim
SFSuat Fitöz
Suat Fitöz
ZÖZ. Birsin Özçakar
Z. Birsin Özçakar
BBBerk Burgu
Berk Burgu
TSTarkan Soygür
Tarkan Soygür

18 August 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
GOGizem Ozcan
Gizem Ozcan
SCSemsa Cayci
Semsa Cayci
BABanu Celikel Acar
Banu Celikel Acar
OBOzge Basaran
Ozge Basaran
FAFatma Aydin
Fatma Aydin
NCNilgun Cakar
Nilgun Cakar

5 December 2013 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
FCFatma Semsa Cayci
Fatma Semsa Cayci
MEMesiha Ekim
Mesiha Ekim
YEYonca Egin
Yonca Egin
HGHafize Gökce
Hafize Gökce
FYFatos Yalcinkaya
Fatos Yalcinkaya
NANejat Akar
Nejat Akar
The pathogenesis of Henoch–Schönlein Purpura (HSP) has not been clearly defined. Inflammatory cytokines have been associated with HSP but there are only a few reports that have focused on coagulation. The endothelial protein C receptor (EPCR), which has anticoagulant and antiinflammatory activity, is the key component of the protein C pathway. Recent studies have implicated the soluble form of EPCR (sEPCR) in Wegener's granulomatosis, Behçet's disease, and systemic lupus erythematosus. The aim of this study was to evaluate the levels of sEPCR in HSP children. Twenty-two children with HSP and 17 healthy children were included. We found no significant differences (P > .05) between patient and control groups in the levels of von Willebrand factor and thrombomodulin. The median sEPCR values in the HSP group were lower than the control group (79 vs. 102 ng/mL, respectively) (P > .05). The mean sEPCR value in HSP patients with severe abdominal pain was lower than without (88.8 ± 54.9 vs. 108.2 ± 66.3 ng/mL, respectively) (P > .05). In addition, the mean IL-6 serum levels were significantly elevated in HSP patients during the acute stage of HSP (2.1 ± 1.7 vs. 1.5 ± 1.2 pg/mL, P = .038). We also observed a slight negative correlation between the levels of sEPCR and IL-6 (R = −.135, P > .05). To our knowledge, this was the first study to analyze sEPCR levels in HSP. Our results did not conclusively identify a direct role of sEPCR in HSP, but our findings warrant further investigations, especially in severe HSP cases characterized by gastrointestinal bleeding or renal involvement.

27 June 2025 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MİMihriban İnözü
Mihriban İnözü
GBGönül Büyükyılmaz
Gönül Büyükyılmaz
BABegüm Avcı
Begüm Avcı
IAIsmail Selcuk Aygar
Ismail Selcuk Aygar
FÇFatma Semsa Çaycı
Fatma Semsa Çaycı
UBUmut Selda Bayrakçı
Umut Selda Bayrakçı
This study aims to determine the role of urinary plasminogen, a serine protease that reflects damage to the glomerular filtration barrier, in the early detection of diabetic kidney disease in pediatric patients with type 1 diabetes mellitus (T1DM). Pediatric patients, who had been followed up with T1DM for at least 2 years, and healthy matched controls were included. The association between urine plasminogen (uPlasminogen) levels and urine plasminogen-to-creatinine ratio (uPlgCR) with urine albumin-to-creatinine ratio (uACR) was examined, as well as determining a cut-off value for uPlasminogen to predict microalbuminuria. A total of 56 T1DM patients and 30 healthy matched controls were included. There was no significant difference in eGFR (estimated glomerular filtration rate) and systolic and diastolic blood pressure between the groups. uPlasminogen level was determined to be higher in the albuminuric group than control (p = 0.001) and uPlgCR was higher in the normoalbuminuric and albuminuric groups than control (p = 0.004, p = 0.002, respectively). There was a weak positive correlation between uPlasminogen and uPlgCR with uACR (r 0.38, p = 0.004; r 0.28, p = 0.03, respectively). The diagnostic performance of uPlasminogen in predicting albuminuria was evaluated by ROC-curve analysis, showing an AUC of 0.69 (p = 0.02; 95% CI [0.521–0.861]), with a sensitivity of 75% and specificity of 65.5% at a cut-off value of 7.1 µg/L. Conclusion: A positive correlation was found between uPlasminogen and uPlgCR with albuminuria. Also, uPlasminogen was determined to predict albuminuria. Most importantly, uPlgCR was elevated in diabetic patients before albuminuria developed. uPlgCR may serve as a potential early marker or therapeutic target of DKD, pending further longitudinal validation. What is Known:• Urinary plasminogen correlates with albuminuria in diabetic patients. What is New:• Urinary plasminogen and uPlgCR levels exhibited a significant and positive correlation with uACR. The new findings in this study are that uPlgCR was detected in urine before microalbuminuria develops, and that uPlasminogen predicted albuminuria in pediatric patients with T1DM.

30 October 2019 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
OAOzlem Yuksel Aksoy
Ozlem Yuksel Aksoy
FCFatma Semsa Cayci
Fatma Semsa Cayci
SCSerdar Ceylaner
Serdar Ceylaner
STSibel Alicura Tokgoz
Sibel Alicura Tokgoz
GKGunay Kaplan
Gunay Kaplan
UBUmut Selda Bayrakci
Umut Selda Bayrakci